🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our multi-institutional, real world cohort validating risk factors for surgical POR. Congrats @RavShahMD !!

Does DLI/type of surgery (🔪) predict anastomotic stricture (AS) in CD? Benjamin Cohen MD MAS Ben Click AJG - The American Journal of Gastroenterology 🟠Caveats. yes. but good question + history. ✅AS = 18% ~3 yrs ✅DLI + type of 🔪 do not predict AS. 🟢this is what I expect in the biologic era. journals.lww.com/ajg/fulltext/2…

More data supporting ileocecal resection over medical therapy for ileal Crohns. ⁦@ManasiAgrawalMD⁩ ⁦Millie Long⁩ ⁦Edward Loftus⁩ ⁦GUILD Conference⁩

Stem cells safe and effective in pediatric perianal CD Amy Lee Lightner, MD Jacob Kurowski. 83% clinical and 🩻 healing at 6 mo bit.ly/3U4k0nH

Check out our updates on the recent advances in prediction, prevention, monitoring, and treatment of postoperative Crohn’s disease; highlighting the most recent data over the last 5-10 years! Thanks to Ben Click for the chance to work on this update! link.springer.com/article/10.100…

📢 📢 New American Gastroenterological Association (AGA) guidelines on Fecal Microbiota-Based Therapies 💩💩💩 for Select Gastrointestinal Diseases 📢 📢 ➡️ gastrojournal.org/article/S0016-… 🔥🔥A tweetorial for #GITwitter, published in Gastroenterology 🔥🔥 Follow this🧵

SPICY: Hot off the press at #ECCO2024 / first RCT of mesenteric excision for ileocolic #Crohn #IBDSurgery -> no effect on postop endoscopic recurrence from #AmsterdamMedicalCenter

KONO-S Fabrizio Michelassi RCT PRELIMINARY at ONLY 3-6 month results - NO EFFECT - study will continue for 5 years #Crohn #ECCO24 #ECCO2024 #SoMe4IBD #SoMe4Surgery #IBDSurgery #IBD Crohn's & Colitis Foundation

Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. pubmed.ncbi.nlm.nih.gov/38492903/

SPICY trial The Lancet Gastroenterology & Hepatology Ben Click Stefan Holubar MD MS ▶️ Q: Mesenteric fat in CD MAY be pro-inflammatory, does removing it during ICR help? 🔵RCT: ICR +/- mesenteric rsxn 🔵Outcome: 6m endo 🟢No diff (Fig 3). 🟠Caveats, yes. Interesting? hell yes. thelancet.com/journals/langa…

Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch Maia Kayal MD Edward Barnes MD MPH et al.IBDJournal & CC360 academic.oup.com/ibdjournal/art…

Soaking up the sun between high yield lectures and hands on endoscopy sim at the annual ASGE GI Endoscopy first year fellows course! Mount Sinai Division of Gastroenterology Mount Sinai CACTES

If anyone would like to sponsor our next shawarma post op CD journal club, DMs are open 😉 Love being here at Sinai and getting to go to ASGE with my co fellows—good luck to all the applicants and reach out if any questions!!

Kicking off an “arresting” session at #AHA24 - Robert Ariss from Brigham and Women's Hospital TIMI Study Group discussing evolutionary trends in TTM following cardiac arrest 3CPR Council Critical Care Cardiology Trials Network

Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…

This month's Regueiro Report looks at the REPREVIO study, which found vedolizumab helps prevent CD recurrence after surgery. Another recent study suggests blood-based biomarkers can help identify patients more likely to relapse after stopping infliximab. gastroendonews.com/Inflammatory-B…

The Cohen Lab at Mount Sinai published new research in GUT on stem cell transplants for refractory Crohn’s disease: bit.ly/41Ip7O9. Findings show over 90% of patients had at least partial intestinal healing. Learn more: bit.ly/41vYSKx Mount Sinai Division of Gastroenterology

The winning Lower team reminds you to get your screening colonoscopy 😉 🔦another fantastic year at Sinai “Iron Chef” 👨‍🍳 👩‍🍳